Clinical trials: Reverse Shoulder Prosthesis
Arthropathy of Shoulder Region, Grossly Deficient Rotator Cuff
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
This study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post market surveillance study. The primary objective of this study is to confirm the safety and performance of the Comprehensive Reverse…
- Conditions
- Arthropathy of Shoulder Region, Grossly Deficient Rotator Cuff, Osteoarthritis of the Shoulder, Rheumatoid Arthritis Without Humeral Metaphyseal Defects
- Trial name
- NCT03726554
- Testing
- Comprehensive Reverse Porous Augmented Glenoid, Comprehensive Mini Humeral Tray
- Where
- 6 sites in United States
- Volunteers
- 99 people
- Sponsor
- Zimmer Biomet
Rotator Cuff Tear Arthropathy
Safety Study of Univers® Revers Shoulder Prosthesis
The primary safety objective is to demonstrate that severe device-related complication (Serious Adverse Device Effect = SADE) occur within 2 years after prosthesis implantation at a rate of less than 2%.
- Trial name
- NCT01778777
- Testing
- Universe Reverse Prosthesis
- Where
- Switzerland
- Volunteers
- 166 people
- Sponsor
- Schulthess Klinik
Rotator Cuff Tear Arthropathy
Immobilization in Reverse Shoulder Prosthesis
Reverse shoulder prostheses are the treatment of choice in elderly patients with rotator cuff arthropathy. Traditionally these patients have been immobilized for 3 weeks in the immediate postoperative period in order to have good…
- Trial name
- NCT04645329
- Testing
- shoulder immovilization sling
- Where
- Spain
- Volunteers
- 50 people
- Sponsor
- Hospital del Mar